ELISA 1: 1,000. Western blot 1: 100 - 1: 500. Immunohistochemistry 1: 50 - 1: 100. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.25 mg/mL
Buffer
PBS with 0.09 % (W/V) sodium azide
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
Target
EIF4E2
(Eukaryotic Translation Initiation Factor 4E Family Member 2 (EIF4E2))
4E-LP antikoerper, 4EHP antikoerper, EIF4EL3 antikoerper, IF4e antikoerper, Eif4el3 antikoerper, EIF4E2 antikoerper, id:ibd1007 antikoerper, zgc:110542 antikoerper, zgc:158544 antikoerper, MGC115622 antikoerper, 2700069E09Rik antikoerper, AI036339 antikoerper, AV129531 antikoerper, D0H0S6743E antikoerper, eukaryotic translation initiation factor 4E family member 2 antikoerper, eukaryotic translation initiation factor 4E member 2 antikoerper, eukaryotic translation initiation factor 4E family member 2 L homeolog antikoerper, EIF4E2 antikoerper, Eif4e2 antikoerper, eif4e2 antikoerper, eif4e2.L antikoerper
Hintergrund
EIF4E2 is expressed exclusively in the cytoplasm. This protein recognizes and binds the 7 methylguanosine containing mRNA cap during an early step in the initiation of protein synthesis and facilitates ribosome binding by inducing the unwinding of the mRNAs secondary structures.Synonyms: Eukaryotic translation initiation factor 4E homologous protein, Eukaryotic translation initiation factor 4E type 2, Eukaryotic translation initiation factor 4E-like 3, eIF-4E type 2, eIF4E type 2, eIF4E-like protein 4E-LP, mRNA cap-binding protein 4EHP, mRNA cap-binding protein type 3